関連する実験動画
Updated: Jul 11, 2026
03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
まとめ
丸がんは治療可能ですが,治療の実施が遅れているため,東欧では死亡率が高いままです. 効果的な治療へのアクセスを改善することで,若い成人の命を救うことができます.
科学分野:
- 腫瘍学 腫瘍学
- 公衆衛生は公衆衛生である.
- エピデミオロジー エピデミオロジー
背景:
- 精巣がんは,迅速に診断され治療された場合,高度に治癒可能な悪性腫瘍です.
- 世界的に, testicular がんによる死亡率には大きな格差がある.
- 効果的な治療戦略は利用可能ですが,普遍的に実施されていません.
研究 の 目的:
- 西ヨーロッパ,東ヨーロッパ,米国,日本における臓がん死亡率の傾向を比較する.
- 臓がん死亡率の減少における地理的変動を特定する.
- 進歩が遅い地域における治療アクセシビリティの改善の必要性を強調する.
主な方法:
- 国内死亡率データの分析.
- 精巣がんの年齢標準化死亡率の比較.
- 1970年代以降,さまざまな地域における傾向の調査.
主要な成果:
- 1970年代以降,米国と西ヨーロッパでは,臓がんによる死亡率が約70%低下しています.
- 東欧は1980年代後半 (約20%) から, testicular がんによる死亡率の減少がずっと遅くなっています.
- 東欧では減速が遅いため,多くの予防可能な死亡が起こっており,主に若い成人の間で発生しています.
結論:
- 効果的な臓がん治療戦略は,東欧諸国で実施されなければならない.
- 東欧における治療の格差を解決することは,予防可能な死亡率を減らすために極めて重要です.
- タイムリーで適切な治療は,世界的に丸がんの生存率を改善する鍵です.
さらに関連する動画
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:50Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
関連する概念動画
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...